discussion tree needs completion

profiledadsfav96
module4discussion.docx
Home>Nursing homework help>discussion tree needs completion

Long-acting injectable antipsychotics (LAIs) are an essential component of evidence-based treatment for schizophrenia spectrum disorders and other psychiatric conditions. Understanding the pharmacokinetics, pharmacodynamics, and clinical application of LAIs is critical for safe and effective prescribing in Psychiatric Mental Health Nurse Practitioner (PMHNP) practice.

While theoretical knowledge provides a foundation, translating that knowledge into practical clinical decision-making requires synthesis of pharmacologic principles, patient considerations, and real-world prescribing strategies.

In this Discussion, you will develop a medication-specific clinical decision tree to demonstrate how a selected LAI is used in practice—from mechanism of action through initiation and monitoring. This activity emphasizes the application of psychopharmacologic principles to clinical reasoning and treatment planning.

You will move beyond general concepts and focus on  one specific long-acting injectable antipsychotic. Instead of a traditional written assignment, you will create a  clinical decision-making tool that reflects how a PMHNP would evaluate, initiate, and manage treatment with that medication.

This Discussion is designed to help you:

· Apply pharmacodynamic and pharmacokinetic principles to prescribing 

· Analyze medication-specific initiation protocols and dosing strategies 

· Evaluate ideal versus non-ideal patient populations 

· Integrate safety, monitoring, and clinical considerations 

· Develop practical tools that mirror real-world PMHNP decision-making 

No AI Permitted

· AI tools may not be used at any stage for this assessment

To prepare:

· Review all the Learning Resources.

· Select  ONE long-acting injectable antipsychotic from the approved list below and create a one-page clinical decision tree (flowchart or algorithm) You may use Word, PowerPoint, or Canva. Your decision tree should demonstrate a logical clinical flow, guiding a provider from medication selection through safe initiation and ongoing management.

· Choose ONE of the following LAI Options:

· Haloperidol decanoate

· Fluphenazine decanoate

· Risperidone (Risperdal Consta)

· Paliperidone palmitate (Invega Sustenna / Trinza / Hafyera)

· Aripiprazole (Abilify Maintena or Aristada)

· Olanzapine pamoate

· Your Decision Tree Must Include the Following Components (Medication-Specific)

· Mechanism of Action 

· Dopamine (D2) receptor activity ± serotonin (5-HT2A) effects 

· Any unique pharmacologic features of your selected agent 

· Indications for Use 

· FDA-approved indications 

· Common off-label uses (if applicable) 

· Ideal vs. Non-Ideal Candidates 

· Characteristics of ideal patients (e.g., adherence challenges, diagnostic profile) 

· Patients requiring caution or avoidance (e.g., metabolic risk, EPS sensitivity, comorbidities) 

· Initiation Process (Required Detail) 

· Oral trial requirement 

· Oral overlap or augmentation (if applicable) 

· Initial dosing and titration schedule 

· Loading doses (if applicable) 

· Time to steady state 

· Clinical Considerations 

· Side effect profile (EPS, metabolic, sedation, etc.) 

· Practical considerations (dosing interval, administration requirements) 

· Safety concerns 

· Monitoring Plan 

· Metabolic monitoring (weight, glucose, lipids) 

· EPS assessment 

· Follow-up schedule 

· Your decision tree must also be supported by scholarly resources: 

· Support responses with a minimum of three (3) scholarly sources  

· Use APA format for citations and references 

· Sources should be current and evidence-based 

· References should support pharmacology, dosing, and clinical use 

Respond to at least two peers on two different days, Each response should go beyond summary and demonstrate advanced clinical reasoning and pharmacologic insight and also meet the following requirements:

· Deepen the discussion: 

· Ask one higher-level clinical question (e.g., dosing nuance, patient-specific modification, safety consideration)

· Critically evaluate: 

· Identify one strength of the decision tree

· Evaluate the appropriateness and completeness of the selected LAI pathway

· Pharmacologic & clinical application: 

· Add one additional medication-specific insight, such as: 

· Pharmacokinetic consideration (e.g., half-life, steady state, depot characteristics)

· Alternative dosing or initiation strategy

· Side effect or safety consideration

· Extend the clinical reasoning: 

· Propose a refinement, alternative approach, or patient-specific modification (e.g., comorbid conditions, adherence barriers, metabolic risk)

Scholarly Support Requirements (Peer Responses) 

· Support responses with a minimum of two (2) scholarly sources 

· Use APA format for citations and references

· Sources should be current and evidence-based

REQUIRED SOURCES:

· Stahl, S. M. (2021). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (5th ed.). Cambridge University Press.

· Chapter 4, "Psychosis Schizophrenia, and the Neurotransmitter Networks Dopamine, Serotonin, and Glutamate" (pp. 71–158)

· Chapter 5, "Targeting Dopamine and Serotonin Receptors for Psychosis, Mood, and Beyond: So-Called 'Antipsychotics'" (pp. 159–243)

· American Psychiatric Association. (2020).  The American Psychiatric Association practice guideline for the treatment of patients with schizophreniaLinks to an external site. . https://www.psychiatry.org/File%20Library/Psychiatrists/Practice/Clinical%20Practice%20Guidelines/APA-Draft-Schizophrenia-Treatment-Guideline.pdf

· Meyer, J. M. & Rubio, J. M. (2025).  Clozapine monitoring in the post-REMS world: Some guidance for cliniciansLinks to an external site. . https://www.psychiatrist.com/jcp/clozapine-monitoring-post-rems-world-some-guidance-for-clinicians/

· Utah State University. (n.d.).  Creating study guidesLinks to an external site. . https://www.usu.edu/academic-support/test/creating_study_guides

· Drugs.com. (n.d.).  https://www.drugs.com/ Links to an external site. Note:  Please use this resource to check the most up-to-date box warnings, FDA approvals and indications, recommendations for follow-up evaluations, changes, etc.

· Antipsychotic Medications Note:  Utilize the following medication table to familiarize yourself with the medications aligned with the topics presented this week.

Antipsychotic Medications

Chlorpromazine 

Fluphenazine 

Haloperidol

Loxapine 

Perphenazine 

Aripiprazole

Asenapine

Clozapine 

Iloperidone 

Olanzapine 

Paliperidone

Quetiapine 

Risperidone 

Ziprasidone

Lurasidone 

Brexpiprazole 

Cariprazine 

Lumateperone 

Benztropine

Propranolol

Deutetrabenazine

Valbenazine 

· NEI Psychopharm. (2022, March 15).  Neurodevelopment and neurodegeneration in schizophreniaLinks to an external site.  [Video]. YouTube. https://www.youtube.com/watch?v=ew1O4szfFIslist=PLYAIFzMMgrFpTVhVqfIyB9tPLT43Ec7In&index=13

· NEI Psychopharm. (2023, August 9).  Why would an acetylcholine agonist make psychosis better?Links to an external site.  [Video]. YouTube. https://www.youtube.com/watch?v=D-Ile1oL_K8

· NEI Psychopharm. (2022, May 3).  What does tardive dyskinesia look like? Links to an external site.  [Video]. YouTube. https://youtu.be/M-EwlAJIaI8

· NEI Psychopharm. (2017, May 16).  What does akathisia really feel like?Links to an external site.  [Video]. YouTube. https://youtu.be/FruaWRsFeXc? si=HwjyWYTwAQoPAVmQ

· In your NEI membership:

· Under the Membership tab click Stahl’s Essential Psychopharmacology Video Edition. Click the Stahl’s Essential Video for CME/CE. Complete Chapter 4 and Chapter 5.

RUBRIC:

NURS_6630_Module4_Discussion_Rubric

NURS_6630_Module4_Discussion_Rubric

Criteria

Ratings

Pts

This criterion is linked to a Learning OutcomeDecision Tree

10 to >8.0 ptsExcellentDevelops a one-page clinical decision tree that fully demonstrates a logical clinical flow, guiding a provider from medication selection through safe initiation and ongoing management of the selected LAI option.

8 to >7.0 ptsGoodDevelops a one-page clinical decision tree that moderately demonstrates a logical clinical flow, guiding a provider from medication selection through safe initiation and ongoing management of the selected LAI option.

7 to >6.0 ptsFairDevelops a one-page clinical decision tree that minimally demonstrates a logical clinical flow, and/or minimally guides a provider from medication selection through safe initiation and ongoing management of the selected LAI option.

6 to >0 ptsPoorDoes not adequately develop a one-page clinical decision tree or decision tree does now demonstrate a logical clinical flow, and/or does not guide a provider from medication selection through safe initiation and ongoing management of the selected LAI option.

10 pts

This criterion is linked to a Learning OutcomeMechanism of Action

10 to >8.0 ptsExcellentFully describes the required mechanisms of action outlined in the assignment instructions.

8 to >7.0 ptsGoodModerately describes the required mechanisms of action outlined in the assignment instructions.

7 to >6.0 ptsFairMinimally describes the required mechanisms of action outlined in the assignment instructions.

6 to >0 ptsPoorDoes not adequately describe the required mechanisms of action outlined in the assignment instructions.

10 pts

This criterion is linked to a Learning OutcomeIndications for Use

10 to >8.0 ptsExcellentFully describes the required indications for use outlined in the assignment instructions.

8 to >7.0 ptsGoodModerately describes the required indications for use outlined in the assignment instructions.

7 to >6.0 ptsFairMinimally describes the required indications for use outlined in the assignment instructions.

6 to >0 ptsPoorDoes not adequately describe the required indications for use outlined in the assignment instructions.

10 pts

This criterion is linked to a Learning OutcomeIdeal vs. Non-Ideal Candidates

10 to >8.0 ptsExcellentFully describes/compares the ideal and non-ideal candidates as outlined in the assignment instructions.

8 to >7.0 ptsGoodModerately describes/compares the ideal and non-ideal candidates as outlined in the assignment instructions.

7 to >6.0 ptsFairMinimally describes/compares the ideal and non-ideal candidates as outlined in the assignment instructions.

6 to >0 ptsPoorDoes not adequately describe/compare the ideal and non-ideal candidates as outlined in the assignment instructions.

10 pts

This criterion is linked to a Learning OutcomeInitiation Process

10 to >8.0 ptsExcellentFully describes the initiation process as outlined in the assignment instructions.

8 to >7.0 ptsGoodModerately describes the initiation process as outlined in the assignment instructions.

7 to >6.0 ptsFairMinimally describes the initiation process as outlined in the assignment instructions.

6 to >0 ptsPoorDoes not adequately describe the initiation process as outlined in the assignment instructions.

10 pts

This criterion is linked to a Learning OutcomeClinical Considerations

10 to >8.0 ptsExcellentFully describes the clinical implications as outlined in the assignment instructions.

8 to >7.0 ptsGoodModerately describes the clinical implications as outlined in the assignment instructions.

7 to >6.0 ptsFairMinimally describes the clinical implications as outlined in the assignment instructions.

6 to >0 ptsPoorDoes not adequately describe the clinical implications as outlined in the assignment instructions.

10 pts

This criterion is linked to a Learning OutcomeMonitoring Plan

10 to >8.0 ptsExcellentFully describes a monitoring plan as outlined in the assignment instructions.

8 to >7.0 ptsGoodModerately describes a monitoring plan as outlined in the assignment instructions.

7 to >6.0 ptsFairMinimally describes a monitoring plan as outlined in the assignment instructions.

6 to >0 ptsPoorDoes not adequately describe a monitoring plan as outlined in the assignment instructions.

10 pts

This criterion is linked to a Learning OutcomeScholarly Support

5 to >4.0 ptsExcellentAnalysis is supported with a minimum of 3 peer-reviewed scholarly sources. All sources are cited in APA format without any errors. Student work is original-- no AI-generated text is presented as student’s own, independent work.

4 to >3.0 ptsGoodAnalysis is supported with a minimum of 2 peer-reviewed scholarly sources. All sources are cited in APA format with some minor errors. Student work is original-- no AI-generated text is presented as student’s own, independent work.

3 to >2.0 ptsFairAnalysis is supported with a minimum of 1 peer-reviewed scholarly source. All sources are cited with frequent APA formatting errors. Student work is original-- no AI-generated text is presented as student’s own, independent work.

2 to >0 ptsPoorAnalysis is not supported with peer-reviewed scholarly sources. Missing source citations and/or minimal adherence to APA formatting rules. Student work is not original-- AI-generated text is presented as student’s own, independent work.

5 pts

This criterion is linked to a Learning OutcomeEngagement with Peers: Response 1

5 to >4.0 ptsExcellentResponse consistently demonstrates meaningful, thoughtful, and respectful engagement with peers.

4 to >3.0 ptsGoodResponse sufficiently demonstrates meaningful, thoughtful, and respectful engagement with peers.

3 to >2.0 ptsFairResponse minimally demonstrates meaningful, thoughtful, and respectful engagement with peers.

2 to >0 ptsPoorResponse does not demonstrate meaningful engagement with peers or is missing.

5 pts

This criterion is linked to a Learning OutcomeEngagement with Peers: Response 2

5 to >4.0 ptsExcellentResponse consistently demonstrates meaningful, thoughtful, and respectful engagement with peers.

4 to >3.0 ptsGoodResponse sufficiently demonstrates meaningful, thoughtful, and respectful engagement with peers.

3 to >2.0 ptsFairResponse minimally demonstrates meaningful, thoughtful, and respectful engagement with peers.

2 to >0 ptsPoorResponse does not demonstrate meaningful engagement with peers or is missing.

5 pts

This criterion is linked to a Learning OutcomeTimeliness of initial post

5 ptsExcellentInitial post by Day 3.

0 ptsPoorInitial post after Day 3.

5 pts

This criterion is linked to a Learning OutcomeParticipates on 3 different days by Day 6

5 ptsExcellentParticipates on 3 different days by Day 6.

0 ptsPoorDoes not participate on 3 different days by Day 6.

5 pts

This criterion is linked to a Learning OutcomeGrammar, Mechanics, and Punctuation

5 to >4.0 ptsExcellentUses correct grammar, spelling, and punctuation with no errors.

4 to >3.0 ptsGoodUses correct grammar, spelling, and punctuation with few errors.

3 to >2.0 ptsFairUses correct grammar, spelling, and punctuation with frequent errors.

2 to >0 ptsPoorPost contains frequent errors in grammar, spelling, and punctuation that interfere with comprehension.

5 pts

Total Points: 100